跳至主要内容
临床试验/NCT04116983
NCT04116983已完成不适用

Effectiveness of an Image Analysing Algorithm (DERM) to Diagnose Non-melanoma Skin Cancer (NMSC) and Benign Skin Lesions Compared to Gold Standard Clinical and Histological Diagnosis

Skin Analytics Limited3 个研究点 分布在 1 个国家目标入组 572 人开始时间: 2020年6月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
572
试验地点
3
主要终点
AUROC of DERM performance when analysing images of biopsied lesions

研究概览

简要总结

This study aims to establish the effectiveness of an Artificial Intelligence (AI) algorithm (DERM) to determine the presence of Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) and frequently observed benign conditions, when used to analyse images of skin lesions taken by commonly available smart phone cameras.

详细描述

DERM, an Artificial Intelligence (AI)-based diagnosis support tool, has been shown to be able to accurately identify Non-melanoma skin cancers (NMSC) and other conditions from historical images of suspicious skin lesions (moles). This study aims to establish how well DERM determines the presence of these conditions in images of skin lesions collected in a clinical setting.

Suspicious skin lesions that are due to be assessed by a dermatologist and a patch of healthy skin will be photographed using three commonly available smart phone cameras with a specific lens attachment. The images will be analysed by DERM, and the results compared to the clinician's diagnosis (all lesions) and histologically-conformed diagnosis (any lesion that is biopsied).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant is willing and able to give informed consent for participation in the study,
  • Male or Female, aged 18 years or above,
  • Have at least suspicious skin lesion which is suitable for photographing (<15mm, not located on an anatomical site inappropriate to photograph (genitalia, hair-bearing areas, under nails), not previously biopsied, not located in an area of visible scarring or tattooing),
  • In the Investigator's opinion, able and willing to comply with all study requirements.

排除标准

  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participant at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study

结局指标

主要结局

AUROC of DERM performance when analysing images of biopsied lesions

时间窗: Study completion

Area Under the Receiver Operating Characteristic Curve (AUROC) of the DERM result of biopsied lesions, using histopathological-confirmed diagnosis as gold standard

次要结局

  • The false positive rate of DERM when used to assess non-biopsied lesions(Study completion: on average 2 days)
  • The proportion of skin lesions with at least 1 readable image that can be analysed by DERM(Study completion: on average 2 days)
  • The specificity of DERM when used to assess biopsied lesions(Study completion: on average 2 days)
  • The false positive rate of DERM when used to assess biopsied lesions(Study completion: on average 2 days)
  • The positive predictive value of DERM when used to assess biopsied lesions(Study completion: on average 2 days)
  • The sensitivity of DERM when used to assess biopsied lesions(Study completion: on average 2 days)
  • The sensitivity of DERM when used to assess non-biopsied lesions(Study completion: on average 2 days)
  • The specificity of DERM when used to assess non-biopsied lesions(Study completion: on average 2 days)
  • Concordance of clinician assessment with histologically confirmed diagnosis(Study completion: on average 2 days)
  • The false negative rate of DERM when used to assess biopsied lesions(Study completion: on average 2 days)
  • The negative predictive value of DERM when used to assess biopsied lesions(Study completion: on average 2 days)
  • The false negative rate of DERM when used to assess non-biopsied lesions(Study completion: on average 2 days)
  • The positive predictive value of DERM when used to assess non-biopsied lesions(Study completion: on average 2 days)
  • AUROC of DERM performance when analysing images of non-biopsied lesions(Study completion: on average 2 days)
  • The negative predictive value of DERM when used to assess non-biopsied lesions(Study completion: on average 2 days)
  • The concordance of DERM result generated using images from each camera(Study completion: on average 2 days)
  • The proportion of skin lesions with 3 images that can be analysed by DERM;(Study completion: on average 2 days)

研究者

发起方
Skin Analytics Limited
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验